SCHEMBL13299334

SCHEMBL13299334

COc1ccc(-c2nc(-c3ccc(C)cc3)nc(-c3cccc(OC)c3O)n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
NPC1 O15118 3/20 0.52
MAPT P10636 9/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
TP53 P04637 2/20 0.48
KDM4E B2RXH2 1/20 0.47
PKM P14618 1/20 0.47
NPSR1 Q6W5P4 2/20 0.46
RAB9A P51151 2/20 0.46
HIF1A Q16665 4/20 0.44
HTT P42858 2/20 0.44
ALDH1A1 P00352 2/20 0.44
GAA P10253 1/20 0.44
LMNA P02545 1/20 0.44
ALOX5 P09917 1/20 0.43
AVPR2 P30518 1/20 0.41
OXTR P30559 1/20 0.41
AVPR1A P37288 1/20 0.41
RAD52 P43351 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12216378 0.94 MEN1 (0.56) MEN1KMT2ANPC1MAPTSMN1; SMN2
SCHEMBL14085534 0.89 MAPT (0.45) MEN1KMT2ANPC1MAPTSMN1; SMN2
SCHEMBL13299329 0.88 NPC1 (0.47) MEN1KMT2ANPC1MAPTSMN1; SMN2
SCHEMBL6509217 0.83 NR1H4 (0.49) MEN1KMT2ANPC1MAPTSMN1; SMN2
SCHEMBL15908123 0.82 MAPT (0.56) MEN1KMT2ANPC1MAPTSMN1; SMN2
SCHEMBL13299328 0.82 MAPT (0.56) MEN1KMT2ANPC1MAPTSMN1; SMN2
SCHEMBL6520111 0.81 NPC1 (0.48) MEN1KMT2ANPC1MAPTSMN1; SMN2
SCHEMBL12251006 0.81 KMT2A (0.54) MEN1KMT2ANPC1MAPTSMN1; SMN2
SCHEMBL14007025 0.81 MEN1 (0.47) MEN1KMT2ANPC1MAPTSMN1; SMN2
SCHEMBL19175445 0.79 MAPT (0.66) MEN1KMT2ANPC1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9669243-B2 Delivery of hydrophobic benefit agents from bodywashes and the like onto a keratinous substrate BASF SE (DE) 2017-06-06 US disclosed
US-20100135936-A1 Delivery of hydrophobic benefit agents from bodywashes and the like onto a keratinous substrate BASF SE (DE) 2010-06-03 US disclosed
US-20080247976-A1 water-resistant cosmetic or dermatological compositions for the UV-photoprotection of human skin and/or hair with enhanced stability to water DUEVA-KOGANOV OLGA V 2008-10-09 US disclosed
US-20080247975-A1 Sunscreen and personal care compositions comprising a select copolymer CIBA CORP. 2008-10-09 US disclosed
US-20080019929-A1 Micro-Particulate Organic Uv Absorber Composition CIBA SPECIALTY CHEMICALS CORP. 2008-01-24 US disclosed
EP-1213013-B1 Process for preparing solid compositions of water-soluble, hardly water-soluble or water-insoluble active agents BASF AG (DE) 2007-04-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080247976-A1 water-resistant cosmetic or dermatological compositions for the UV-photoprotection of human skin and/or hair with enhanced stability to water CUTA, POLR1C, MSH6 MEN1 1461/4885KMT2A 3806/4885NPC1 4533/4885
US-20080247975-A1 Sunscreen and personal care compositions comprising a select copolymer MSH6, CUTA, ERCC5 MEN1 777/4885KMT2A 4065/4885NPC1 3891/4885
US-20100135936-A1 Delivery of hydrophobic benefit agents from bodywashes and the like onto a keratinous substrate KRT18, ABHD16A, CUTA MEN1 3484/4885KMT2A 346/4885NPC1 2885/4885
US-20080019929-A1 Micro-Particulate Organic Uv Absorber Composition PCNA, FASN, CCNO MEN1 367/4885KMT2A 4285/4885NPC1 413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.